$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024070724 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$659.9K	$863.5K	$414.1K
YoY Change	-18.93%	108.56%	-23.38%
Cost Of Revenue	$381.8K	$425.0K	$209.1K
YoY Change	10.14%	103.26%	-0.3%
Gross Profit	$278.1K	$438.6K	$205.0K
YoY Change	-40.49%	113.96%	-38.01%
Gross Profit Margin	42.15%	50.79%	49.51%
Selling, General & Admin	$630.0K	$619.1K	$768.9K
YoY Change	10.53%	-19.49%	5.04%
% of Gross Profit	226.54%	141.15%	375.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.08K	$24.51K	$20.55K
YoY Change	30.4%	19.3%	-9.71%
% of Gross Profit	9.38%	5.59%	10.02%
Operating Expenses	$641.2K	$630.9K	$776.8K
YoY Change	10.17%	-18.78%	4.67%
Operating Profit	-$363.1K	-$192.4K	$3.480M
YoY Change	216.72%	-105.53%	-945.66%
Interest Expense	-$88.45K		$166.2K
YoY Change	-250.71%		-54.13%
% of Operating Profit			4.78%
Other Income/Expense, Net	-$309.7K	$50.00K	$294.4K
YoY Change	526.39%	-83.02%
Pretax Income	-$672.7K	-$246.0K	$3.774M
YoY Change	320.46%	-106.52%	-473.93%
Income Tax
% Of Pretax Income
Net Earnings	-$672.7K	-$246.0K	$3.774M
YoY Change	310.03%	-106.52%	-473.93%
Net Earnings / Revenue	-101.95%	-28.48%	911.54%
Basic Earnings Per Share	$0.00	$0.00	$0.01
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	550.5M shares	545.3M shares	505.0M shares
Diluted Shares Outstanding	545.3M shares	543.2M shares	2.349B shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.67K	$196.3K	$1.512M
YoY Change	-98.08%	-87.01%	518.09%
Cash & Equivalents	$21.67K	$196.3K	$1.512M
Short-Term Investments
Other Short-Term Assets	$86.44K	$107.8K	$66.95K
YoY Change	188.13%	61.03%	-38.77%
Inventory	$146.4K	$162.1K	$119.1K
Prepaid Expenses			$16.95K
Receivables	$226.6K	$243.4K	$133.3K
Other Receivables	$21.96K	$71.96K	$0.00
Total Short-Term Assets	$586.6K	$841.4K	$1.831M
YoY Change	-62.13%	-54.05%	174.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$176.5K	$147.8K	$79.05K
YoY Change	-4.0%	87.03%	-31.03%
Goodwill	$350.5K	$350.5K	$350.5K
YoY Change	0.0%	0.0%	0.0%
Intangibles	$191.5K	$204.2K	$254.7K
YoY Change	-20.87%	-19.83%	-16.55%
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets
YoY Change
Total Long-Term Assets	$831.8K	$831.2K	$870.8K
YoY Change	-12.37%	-4.55%	-27.9%
TOTAL ASSETS
Total Short-Term Assets	$586.6K	$841.4K	$1.831M
Total Long-Term Assets	$831.8K	$831.2K	$870.8K
Total Assets	$1.418M	$1.673M	$2.702M
YoY Change	-43.22%	-38.09%	44.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$812.6K	$798.8K	$729.7K
YoY Change	12.14%	9.47%	-12.03%
Accrued Expenses	$379.5K	$390.3K	$390.8K
YoY Change	-6.53%	-0.13%	-23.99%
Deferred Revenue	$130.5K	$148.8K
YoY Change	-4.38%
Short-Term Debt	$654.1K	$180.0K	$1.031M
YoY Change	-36.5%	-82.55%	155.22%
Long-Term Debt Due	$271.6K	$474.0K	$83.21K
YoY Change	239.55%	469.66%	-92.63%
Total Short-Term Liabilities	$2.373M	$2.107M	$2.907M
YoY Change	-15.98%	-27.52%	-16.01%
LONG-TERM LIABILITIES
Long-Term Debt	$1.829M	$861.6K	$5.550K
YoY Change	2948.73%	15423.78%	-97.95%
Other Long-Term Liabilities	$53.04K	$67.95K	$128.7K
YoY Change	-51.78%	-47.21%	-59.78%
Total Long-Term Liabilities	$1.882M	$929.5K	$134.3K
YoY Change	987.55%	592.28%	-77.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.373M	$2.107M	$2.907M
Total Long-Term Liabilities	$1.882M	$929.5K	$134.3K
Total Liabilities	$4.255M	$3.037M	$3.041M
YoY Change	41.96%	-0.15%	-24.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$62.09M	-$61.45M	-$59.63M
YoY Change	3.77%	3.04%	-1.35%
Common Stock	$545.3K	$545.3K	$523.2K
YoY Change	2.33%	4.21%	70.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.988M	-$4.341M	-$454.9K
YoY Change
Total Liabilities & Shareholders Equity	$1.418M	$1.673M	$2.702M
YoY Change	-43.22%	-38.09%	44.15%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$672.7K	-$246.0K	$3.774M
YoY Change	310.03%	-106.52%	-473.93%
Depreciation, Depletion And Amortization	$26.08K	$24.51K	$20.55K
YoY Change	30.4%	19.3%	-9.71%
Cash From Operating Activities	-$324.5K	-$160.8K	-$622.0K
YoY Change	1.4%	-74.15%	110.43%
INVESTING ACTIVITIES
Capital Expenditures	$42.16K
YoY Change	-61.67%
Acquisitions
YoY Change
Other Investing Activities			$4.043M
YoY Change
Cash From Investing Activities	-$42.16K		$4.043M
YoY Change	-61.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	192.0K	159.3K	-1.992M
YoY Change	219.97%	-108.0%	-638.34%
NET CHANGE
Cash From Operating Activities	-324.5K	-160.8K	-622.0K
Cash From Investing Activities	-42.16K		4.043M
Cash From Financing Activities	192.0K	159.3K	-1.992M
Net Change In Cash	-174.6K	-1.540K	1.429M
YoY Change	-52.8%	-100.11%	1819.05%
FREE CASH FLOW
Cash From Operating Activities	-$324.5K	-$160.8K	-$622.0K
Capital Expenditures	$42.16K
Free Cash Flow	-$366.6K
YoY Change	-14.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53029
	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2029 Pat Booker Rd
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Antonio
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78148
	dei	City Area Code CityAreaCode	210
	dei	Local Phone Number LocalPhoneNumber	490-3977
	dei	Security12b Title Security12bTitle	N/A
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	550503623	shares
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196315	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	243369	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	162052	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	107807	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28503	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	71961	usd
CY2024Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	59856	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	2400	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	841360	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1373118	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147842	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	128722	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	204163	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2024Q2	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	831218	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	909995	usd
CY2024Q2	us-gaap	Assets Assets	1672578	usd
CY2023Q4	us-gaap	Assets Assets	2283113	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2024Q2	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	474014	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	798827	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	710222	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	390258	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	474515	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54462	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	717204	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	148784	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	500720	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60773	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2107118	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2725072	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	828091	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2024Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	33477	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	67949	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	929517	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1057449	usd
CY2024Q2	us-gaap	Liabilities Liabilities	3036635	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3782521	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	cbnt	Preferred Stock Shares Designated PreferredStockSharesDesignated	100000	shares
CY2023Q4	cbnt	Preferred Stock Shares Designated PreferredStockSharesDesignated	100000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	545253623	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	545253623	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532818051	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532818051	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	545254	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	532818	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56561018	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55852477	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61447146	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60851714	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4340874	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4466419	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	155601	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	141884	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4185273	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1672578	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2283113	usd
CY2024Q2	us-gaap	Revenues Revenues	863533	usd
CY2023Q2	us-gaap	Revenues Revenues	414055	usd
	us-gaap	Revenues Revenues	1800337	usd
	us-gaap	Revenues Revenues	929275	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	424959	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	209071	usd
	us-gaap	Cost Of Revenue CostOfRevenue	886888	usd
	us-gaap	Cost Of Revenue CostOfRevenue	454431	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	438574	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	204984	usd
	us-gaap	Gross Profit GrossProfit	913449	usd
	us-gaap	Gross Profit GrossProfit	474844	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	30046	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	376968	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
CY2024Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	373548	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	441181	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1152667	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	868053	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	88030	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	193263	usd
	us-gaap	Professional Fees ProfessionalFees	229614	usd
	us-gaap	Professional Fees ProfessionalFees	380953	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	169357	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	142404	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	365048	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	321304	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	630935	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	776848	usd
	us-gaap	Operating Expenses OperatingExpenses	1747329	usd
	us-gaap	Operating Expenses OperatingExpenses	1570310	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4051709	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4051709	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-192361	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3479845	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-833880	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2956243	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	462581	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	347990	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	462581	usd
CY2024Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	53608	usd
CY2023Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	166189	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	67727	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	361975	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1964	usd
	us-gaap	Interest Expense InterestExpense	5663	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-53608	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	294428	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	280263	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	94943	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-245969	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
	us-gaap	Profit Loss ProfitLoss	-553617	usd
	us-gaap	Profit Loss ProfitLoss	3051186	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4207	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-18640	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13717	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35362	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	13749	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	13618	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	28098	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	27305	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-263925	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3779295	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-595432	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3059243	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	543165027	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	493056689	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539431386	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458283435	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	543165027	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2349380186	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	539431386	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2314606932	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4324535	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	40000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	127640	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	14349	usd
CY2024Q1	cbnt	Adjustment To Additional Paid In Capital Beneficialconversionchargeforissuanceof Series Bpreferredsharesforaccruedcompensation AdjustmentToAdditionalPaidInCapitalBeneficialconversionchargeforissuanceofSeriesBpreferredsharesforaccruedcompensation	326968	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-307648	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4151924	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	206369	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13749	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-245969	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4185273	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023Q1	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	40000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	53000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	101400	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13687	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	12137	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2023Q2	cbnt	Stock Issued During Period Value For Professional Fees StockIssuedDuringPeriodValueForProfessionalFees	39450	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	26000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	82600	usd
CY2023Q2	cbnt	Stock Issued During Period Value For Conversion Of Debt Accrued Interest And Fees StockIssuedDuringPeriodValueForConversionOfDebtAccruedInterestAndFees	200389	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13618	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4046	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3167766	usd
	us-gaap	Profit Loss ProfitLoss	-553617	usd
	us-gaap	Profit Loss ProfitLoss	3051186	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49015	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	41395	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	22459	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	95922	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	2250	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	376968	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	97817	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	347990	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	462581	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4051709	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	732	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	660	usd
	cbnt	Indemnification Expense IndemnificationExpense	-21961	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25833	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-154889	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-188934	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19611	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	51196	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	79304	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	15434	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	57456	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	52487	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	50000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	88605	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-50027	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-84257	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8040	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	5663	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3645	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	49812	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-351936	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	157363	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-812054	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-912997	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4042631	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4042631	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	405550	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	175000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	43642	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1792448	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	90000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	222750	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	271908	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1715198	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-540146	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1414436	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736461	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196315	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1511527	usd
	us-gaap	Interest Paid Net InterestPaidNet	26561	usd
	us-gaap	Interest Paid Net InterestPaidNet	199122	usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	79450	usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1	78000	usd
	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	312000	usd
	cbnt	Preferred Stock Issued For Accrued Compensation PreferredStockIssuedForAccruedCompensation	144000	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	28098	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	27305	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	60000	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	184000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	194000	usd
	cbnt	Reclassification Of Series B Preferred Stock To Additional Paidin Capital ReclassificationOfSeriesBPreferredStockToAdditionalPaidinCapital	334009	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and owner and developer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Prior to May 8, 2023, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™. Since May 8, 2023, the date that the nanoShield<sup>TM </sup>product line and related technologies were sold (see Note 16), the Company has operated in one segment. Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry-resistant system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder. Pursuant to the Exchange Agreement, on July 22, 2021, the Company acquired 80% of Patriot Glass’s units (the “Patriot Glass Shares”). The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement (the Exchange Agreement as amended, or the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending at 5:00 P.M. EST on the date that is 30 calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions, LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield<sup>TM</sup> division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).</span></p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2023Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	us-gaap	Profit Loss ProfitLoss	-553617	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-812054	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-912997	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61447146	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4185273	usd
CY2024Q2	cbnt	Working Capital WorkingCapital	1265758	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	196315	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the six months ended June 30, 2024 and 2023 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions. </span></p>
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-263925	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3779295	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-595432	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3059243	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	543165027	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	493056689	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539431386	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458283435	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-263925	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3779295	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-595432	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3059243	usd
CY2023Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	13618	usd
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	27305	usd
CY2023Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	52618	usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	102639	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-263925	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3845531	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-595432	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3189187	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	543165027	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	493056689	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539431386	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458283435	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	543165027	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2349380186	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	539431386	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2314606932	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2068924169	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1898769195	shares
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk and Uncertainties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.</span></p>
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	304525	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	459414	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	61156	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35323	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	243369	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424091	usd
	cbnt	Bad Debt Expense BadDebtExpense	23094	usd
	cbnt	Net Of Bad Debt Recovery NetOfBadDebtRecovery	2739	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	162052	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	181663	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	162052	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	181663	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	254167	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	106325	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82561	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147842	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	352516	usd
CY2024Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	148353	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	123102	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	204163	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	229414	usd
CY2024Q2	us-gaap	Goodwill Goodwill	350491	usd
CY2023Q4	us-gaap	Goodwill Goodwill	350491	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25251	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25252	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3157	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	104163	usd
CY2024Q2	cbnt	Outstanding Principal Balance Rate OutstandingPrincipalBalanceRate	1.25	pure
CY2024Q2	cbnt	Accrued Interest Rate Per Anum AccruedInterestRatePerAnum	0.18	pure
	cbnt	Debt Instrument Trading Days DebtInstrumentTradingDays	P10D
CY2024Q2	us-gaap	Derivative Net Assets Percentage DerivativeNetAssetsPercentage	0.50	pure
	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.00875
CY2022Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
CY2023Q4	cbnt	Aggregate Payment AggregatePayment	1113091	usd
	cbnt	Gross Proceeds GrossProceeds	0.20	pure
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	120000	usd
CY2023Q4	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	15000	usd
CY2024Q1	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.20	pure
CY2024Q2	cbnt	Principal And Accrued Interest PrincipalAndAccruedInterest	0.15	pure
CY2024Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	176184	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	90731	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	119943	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	119943	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1008091	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1098091	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1008091	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1098091	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	180000	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	828091	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	918091	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	567333	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	124781	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	59842	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	764	usd
CY2024Q2	us-gaap	Notes Payable To Bank NotesPayableToBank	507491	usd
CY2023Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	124017	usd
CY2024Q2	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	474014	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	81908	usd
CY2024Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	33477	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	42109	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2023Q2	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	317293	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	998008	shares
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	160880	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	cbnt	Maturity Terms MaturityTerms	P12M
CY2022Q3	cbnt	Common Stock Trading Price Per Share CommonStockTradingPricePerShare	0.009
CY2024Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	157000	usd
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	0	usd
CY2024Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2024Q2	us-gaap	Workers Compensation Discount Percent WorkersCompensationDiscountPercent	0.35	pure
CY2024Q2	cbnt	Percentage Of Outstanding Shares Common Stock PercentageOfOutstandingSharesCommonStock	0.0499	pure
CY2024Q2	cbnt	Monthly Payments Of Principal And Interest MonthlyPaymentsOfPrincipalAndInterest	P9M
CY2024Q2	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	8775	usd
CY2024Q2	us-gaap	Workers Compensation Discount Percent WorkersCompensationDiscountPercent	0.35	pure
CY2024Q2	cbnt	Percentage Of Outstanding Shares Common Stock PercentageOfOutstandingSharesCommonStock	0.0499	pure
CY2022Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	200000	usd
CY2022Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	22459	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	93295	usd
	cbnt	Preferred Stock Convertible Conversion Percentage PreferredStockConvertibleConversionPercentage	1	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.059
CY2024Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	95161	usd
CY2024Q1	cbnt	Compensation Stated Value CompensationStatedValue	50000	usd
CY2024Q1	cbnt	Initial Conversion Closing Price InitialConversionClosingPrice	0.0031
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.059
	us-gaap	Dividends Dividends	55690	usd
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
CY2024Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	6131037	shares
CY2024Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	20000	usd
CY2024Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	14743	usd
CY2023Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	16079	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1575903	usd
CY2024Q2	cbnt	Preferred Stock Stated Value PreferredStockStatedValue	1455000	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	120903	usd
CY2023	cbnt	Preferred State Value Inclued Liquidations PreferredStateValueIncluedLiquidations	1515000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	275000	shares
CY2023Q1	cbnt	Stock Issued During Period Value For Accrued Compensation StockIssuedDuringPeriodValueForAccruedCompensation	53000	usd
CY2023Q1	cbnt	Stock Issued During Period Shares For Accrued Compensation StockIssuedDuringPeriodSharesForAccruedCompensation	9636364	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6666667	shares
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.006
	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	11667	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	28333	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5000000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22500	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0045
CY2023Q2	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	22500	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16950	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0011
CY2023Q2	cbnt	Stockbased Professional Fees stockbasedProfessionalFees	5650	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	11300	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42183	usd
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62000	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	132000	usd
CY2023Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	82600	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
	cbnt	Voting Percentage VotingPercentage	0.10	pure
	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	50000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	11445698	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	29451070	shares
CY2024Q2	us-gaap	Cash Cash	21961	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	175000	usd
CY2024Q1	us-gaap	Escrow Deposit EscrowDeposit	225000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	175000	usd
CY2024Q2	us-gaap	Other Expenses OtherExpenses	50000	usd
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	120	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	5250000	shares
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	347097	usd
CY2017Q4	cbnt	Annual Base Salary AnnualBaseSalary	300000	usd
CY2017Q4	cbnt	Annual Base Salary Rate AnnualBaseSalaryRate	0.10	pure
CY2017Q4	us-gaap	Public Utilities Amount Of Allowance For Funds Used During Construction Equity Costs Capitalized Only For Rate Making Purposes PublicUtilitiesAmountOfAllowanceForFundsUsedDuringConstructionEquityCostsCapitalizedOnlyForRateMakingPurposes	1000000	usd
CY2017Q4	cbnt	Capital Raise Rate CapitalRaiseRate	0.05	pure
CY2017Q4	cbnt	Common Stock Shares Acquired CommonStockSharesAcquired	3000000	shares
CY2017Q4	cbnt	Common Stock Shares Acquired Per Share CommonStockSharesAcquiredPerShare	0.31
CY2017Q4	cbnt	Stock Options Shares Issued StockOptionsSharesIssued	500000	shares
CY2017Q4	cbnt	Strike Price StrikePrice	0.85
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
CY2021Q3	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2023	cbnt	Bonus Percentage BonusPercentage	0.10	pure
CY2023	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	162000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	312000	usd
CY2024Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	312	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
	cbnt	Issued Percentage IssuedPercentage	0.20	pure
	cbnt	Outstanding Percentage OutstandingPercentage	0.20	pure
	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
	cbnt	Option Period Percentage OptionPeriodPercentage	0.20	pure
CY2023Q3	cbnt	Share Value Percentage ShareValuePercentage	3	pure
CY2023Q4	cbnt	Nonrefundable Cash Fee NonrefundableCashFee	25000	usd
CY2023Q4	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.065	pure
CY2023Q4	cbnt	Break Up Fee Percentage BreakUpFeePercentage	0.10	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2024Q2	us-gaap	Revenues Revenues	863533	usd
CY2023Q2	us-gaap	Revenues Revenues	414055	usd
	us-gaap	Revenues Revenues	1800337	usd
	us-gaap	Revenues Revenues	929275	usd
CY2024Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	24508	usd
CY2023Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	20545	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	49015	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	41395	usd
CY2024Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	53608	usd
CY2023Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	168153	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	67727	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	367638	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-245969	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
	us-gaap	Profit Loss ProfitLoss	-553617	usd
	us-gaap	Profit Loss ProfitLoss	3051186	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147842	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171606	usd
	us-gaap	Revenues Revenues	1800337	usd
	us-gaap	Revenues Revenues	929275	usd
CY2019Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P18M
CY2020	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	5283	usd
	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
	us-gaap	Sale Leaseback Transaction Lease Term SaleLeasebackTransactionLeaseTerm	P12Y
	us-gaap	Operating Lease Payments OperatingLeasePayments	16800	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	40845	usd
CY2024Q2	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2023Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2024Q2	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	150440	usd
CY2023Q4	cbnt	Operating Lease Right Of Use Asset Amortization Accumulated Amortization OperatingLeaseRightOfUseAssetAmortizationAccumulatedAmortization	120678	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	128722	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158484	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	128722	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157752	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60773	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	60503	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	67949	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97249	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	72715	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	67200	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5600	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	145515	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	16793	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	128722	usd
CY2022Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	175000	usd
CY2024Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	50000	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	21961	usd
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4000000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1989755	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	17877	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	160893	usd
CY2024Q2	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.65	pure
CY2024Q2	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.35	pure
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.65	pure
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.35	pure
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q2	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	cbnt	Stockbased Professional Fee StockbasedProfessionalFee		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	cbnt	Indemnification Expense IndemnificationExpense		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices		usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	cbnt	Reclassification Of Series B Preferred Stock To Additional Paidin Capital ReclassificationOfSeriesBPreferredStockToAdditionalPaidinCapital		usd
CY2024Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax		usd
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax		usd
CY2024Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
	cbnt	Bad Debt Expense BadDebtExpense		usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
0001213900-24-070724-index-headers.html	Edgar Link	pending
0001213900-24-070724-index.html	Edgar Link	pending
cbnt-20240630_cal.xml	Edgar Link	unprocessable
0001213900-24-070724.txt	Edgar Link	pending
0001213900-24-070724-xbrl.zip	Edgar Link	pending
cbnt-20240630.xsd	Edgar Link	pending
ea0211070-10q_cbond.htm	Edgar Link	pending
ea021107001ex31-1_cbond.htm	Edgar Link	pending
ea021107001ex31-2_cbond.htm	Edgar Link	pending
ea021107001ex32-1_cbond.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
cbnt-20240630_def.xml	Edgar Link	unprocessable
cbnt-20240630_pre.xml	Edgar Link	unprocessable
cbnt-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0211070-10q_cbond_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2024 Q3 Form 10-Q Financial Statement

#000121390024070724 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2024 Q3 Form 10-Q Financial Statement

#000121390024070724 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt